Influence of Hepatitis C Virus Infection on HIV‐1 Disease Progression and Response to Highly Active Antiretroviral Therapy
Jürgen K. Rockstroh(University of Bonn), Vincent Soriano(Fundación Instituto Valenciano de Oncología), Ole Kirk(University of Copenhagen), Amanda Mocroft(University of Copenhagen), Andrzej Horban(Medical University of Warsaw), Jens Lundgren(Centre of Excellence for Health, Immunity and Infections), Cristina Tural(Universitat Autònoma de Barcelona), Bruno Ledergerber(University Hospital of Zurich), Andrew Phillips(Wake Forest University), M Losso(Hospital Ramos Mejía)
Cited by 385
Related Papers
Industrial enzyme applications
|Current Opinion in Biotechnology|2002|1.5k
Decline in the AIDS and death rates in the EuroSIDA study: an observational study
|The Lancet|2003|1.2k
Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD study
|AIDS|2003|987
Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration
|The Lancet|2014|930
One Biocatalyst–Many Applications: The Use of Candida Antarctica B-Lipase in Organic Synthesis
|Biocatalysis and Biotransformation|1998|682